NGOs warn of Big Pharma’s influence on EU drug reform
Several major organisations are suspicious that recent lobbying efforts by pharmaceutical companies could sway the upcoming EU pharmaceutical reform talks in favour of innovation arguments at the expense of patient access.
Several major organisations are suspicious that recent lobbying efforts by pharmaceutical companies could sway the upcoming EU pharmaceutical reform talks in favour of innovation arguments at the expense of patient access.
What's Your Reaction?
